Medicine Recommendations

Prevention of venous thromboembolism after total hip or knee replacement in adults (NICE TA245)

NICE TA245 - Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults

Parkinson's disease

Moderate to severe plaque psoriasis (NICE TA419)

NICE TA419 - Apremilast for treating moderate to severe plaque psoriasis

Active Psoriatic Arthritis (NICE TA433)

NICE TA433 - Apremilast for treating Active Psoriatic Arthritis

Emollient preparation

Bipolar disorder in Adolescents (NICE TA292)

NICE TA 292 - Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder

Bipolar disorder in Adults

Maintenance treatment of schizophrenia in adult patients

Treatment of Schizophrenia in adults. Treatment of Schizophrenia in people aged 15 to 17 years (NICE TA213)

NICE TA213 - Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Acute Mania

Secondary Prevention of stroke (as per LSCMMG Guidelines)

 Acute Migraine

Asthma

ADHD

NICE guideline NG87: Attention deficit hyperactivity disorder: diagnosis and management

MHRA Drug Safety Update - Atomoxetine: increases in blood pressure and heart rate

Treatment of erectile dysfunction in adult men who are unable to tolerate sildenafil and tadalafil

Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA 626)

For the symptomatic treatment of erectile dysfunction in adult males due to neurogenic, vasculogenic, psychogenic, or mixed aetiology.

Inflammatory bowel disease, Rheumatic diseases, Dermatology

For treatment of Myasthenia Gravis

Relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient.